Living donor liver transplantation in polycystic liver disease

Kristin L. Mekeel, Adyr A. Moss, Kunam S. Reddy, David D. Douglas, Hugo E. Vargas, Elizabeth J. Carey, Thomas J. Byrne, M. E. Harrison, Jorge Rakela, David C. Mulligan

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


In the current Model for End-Stage Liver Disease system, patients with polycystic liver disease (PCLD) who have a poor quality of life secondary to their massive hepatomegaly are no longer competitive for a deceased donor liver transplant if their liver function is well preserved. Traditionally, a caval resection has been advocated in these patients because of the difficulty of the hepatectomy with hepatomegaly, which makes living donation impossible. This series looks at 3 patients who underwent a caval sparing hepatectomy and subsequent living donor liver transplantation (LDLT) for PCLD. Graft and patient survival was 100%, and there were few complications in either donors or recipients. LDLT is an ideal option for patients with PCLD and preserved liver function but poor quality of life.

Original languageEnglish (US)
Pages (from-to)680-683
Number of pages4
JournalLiver Transplantation
Issue number5
StatePublished - May 2008

ASJC Scopus subject areas

  • Surgery
  • Hepatology
  • Transplantation


Dive into the research topics of 'Living donor liver transplantation in polycystic liver disease'. Together they form a unique fingerprint.

Cite this